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Background: Coronary computed CT angiography (CCTA) reveals a detailed anatomy of coronary tree and provides a basis for the individualized 
therapy depending on severity of the underlying disease. In post-COURAGE era, however, it is unclear whether the CCTA findings of severe CAD (>70% 
stenosis) would increase the rates of downstream invasive coronary angiograms (ICA) and revascularization (PCI or CABG). Prognostic implications of 
the CCTA findings in patients with newly diagnosed severe CAD remain unclear.
Methods: A total of 1346 patients with no known prior CAD (54% men; age 57±13 yrs, BMI 29.3±6.0) who had CCTA at William Beaumont 
Hospitals, were identified and followed up for at least 1 year. Data regarding patient demographics, referral information, clinical and historical 
variables, CTA findings and short-term post-test outcomes were entered into the registry database prospectively. Rates of ICA, revascularization and 
hard cardiac events (death or MI) were analyzed for the subset of patients with severe CAD (at least one coronary lesion >70% luminal stenosis on 
CCTA).
Results: There were 671 pts (49.9%) with abnormal CCTA; of those,104 pts (15.5%) had severe CAD. All the pts with evidence of CAD on CCTA were 
placed on medical therapy. Only 24 pts (23%) were referred for ICA within 1 month-period and additional 7 pts were referred within 3 month-period 
following CCTA. Of those, 21 pt and 4 pts, respectively, underwent PCI within 1 and 3 months, and a total of 5 pts underwent CABG within the first 
month after the CCTA. No hard events or additional revascularization events were identified in the study population during a 1 year follow-up.
Conclusions: CCTA does not cause an inappropriate increase in ICA rates in pts with newly diagnosed severe CAD; only in <30% of these patients, 
CCTA results lead to ICA and/or revascularization within first 3 months following the scan. A short-term (1 year) prognosis of patients with severe CAD 
on CCTA is favorable following revascularization or medical therapy. A potential change in the natural history of CAD in these patients as a result of 
early revascularization based on CTA findings should be taken in consideration in a future research of the CCTA outcomes.
